Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3042]
News [6141]
Articles [120]
Editorials [18]
Conferences [181]
elearning [32]
What are the objectives for CART-meso immunotherapy?
Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA
What are the objectives for CART-meso immunotherapy? ( Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA )
30 Apr 2015
How will genomics be applied to patient therapy in future?
Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas
How will genomics be applied to patient therapy in future? ( Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas )
30 Apr 2015
New T cell–based immunotherapy shows promise for lethal stem cell transplant...
Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )
30 Apr 2015
Inside cancer - public lecture
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Inside cancer - public lecture ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
29 Apr 2015
The evolution of CLL treatment
Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence...
The evolution of CLL treatment ( Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence Cymbalista )
28 Apr 2015
How to decide the treatment of CLL in 2015
Dr Marco Montillo and Dr Maria Gomes da Silva
How to decide the treatment of CLL in 2015 ( Dr Marco Montillo and Dr Maria Gomes da Silva )
24 Apr 2015
Changing perceptions around controlled drugs for the benefit of patients
Diederik Lohman - Human Rights Watch, New York, USA
Changing perceptions around controlled drugs for the benefit of patients ( Diederik Lohman - Human Rights Watch, New York, USA )
21 Apr 2015
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity...
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Optimizing survival in advanced prostate cancer: Welcome and introduction
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Welcome and introduction ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to...
Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
29 Jan 2015
Optimizing Survival in Advanced Prostate Cancer: Conclusion
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing Survival in Advanced Prostate Cancer: Conclusion ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Big disparities in cancer outcomes within borders as well as across them
Prof Sanchia Aranda - Cancer Institute NSW, Sydney, Australia
Big disparities in cancer outcomes within borders as well as across them ( Prof Sanchia Aranda - Cancer Institute NSW, Sydney, Australia )
18 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation